HealthDay News — There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS Global Public Health.

The H5N1 avian flu is circulating in cows and other mammals. Whether it will make a permanent leap to humans is another question ...

The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

While the new panel showed little conflict over the 2025-2026 seasonal flu vaccine recommendations, thimerosal fueled sharp reactions among members and outside observers.

Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial.

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by private equity firm Nordic Capital.

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

(The Hill) – Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...

Moderna flu shot outperforms marketed vaccines in large late-stage trial The mRNA drug developer said it will begin discussing approval with an FDA that has adopted stricter vaccine review standards.

TribLIVE looked into the history of the flu vaccine and what this new recommendation means for the medical world. What is influenza?

A CDC advisory panel voted 5–1 to recommend only flu vaccines without the preservative thimerosal, a mercury-containing compound used as a preservative in vaccines and other drugs. Doctors and ...